Taboco, Naome .

HRN: 23-03-75  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/17/2023
CEFUROXIME 1.5GM (VIAL)
11/18/2023
11/19/2023
IV
1.5 Grams
PTOR
For TAHBSO
Checking Final Appropriateness 
11/19/2023
CEFUROXIME 750MG (VIAL)
11/19/2023
11/25/2023
IV
1.5gm
Q8
SPTAHBSO
Checking Final Appropriateness 
11/19/2023
CEFUROXIME 500MG (TAB)
11/19/2023
11/26/2023
PO
500 Mg
BID
S/P TAHBSO
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: